IMARC Group, a leading market research company, has recently released a report titled “Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global connected drug delivery devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Connected Drug Delivery Devices Market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 652.9 Million |
| Market Forecast in 2028 | US$ 3,517.0 Million |
| Growth rate (2023 to 2028) | CAGR of 33.6% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is Connected Drug Delivery Devices?
Connected drug delivery devices refer to smart wireless electronic systems that support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors, and monitoring tools to provide instant feedback and education tools for personalized sufferer care. Connected drug delivery devices are convenient and save costs associated with clinic-based treatment. Consequently, they are widely utilized in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, clinically isolated syndrome, multiple sclerosis, chronic obstructive pulmonary disease (COPD), and liver and renal transplant recipients.
Request For a Free PDF Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample
What are the Growth Prospects and Trends in the Connected Drug Delivery Devices Industry?
The increasing expenditure on medical management and the rising need to improve patient treatment outcomes are primarily augmenting the connected drug delivery devices market. Furthermore, the shifting preferences of consumers toward home-based supervision are positively influencing the global market. Apart from this, the inflating number of individuals suffering from chronic diseases and the growing focus on preventive care are acting as significant growth-inducing factors. Moreover, the widespread adoption of these devices in hospitals and laboratories for maintaining electronic health records (EHR) is also bolstering the market growth. Besides this, numerous manufacturers are offering devices that can connect to apps and programs, allow data transfer, enable automated tracking, and maximize sufferer safety, which is further catalyzing the global market. Additionally, the escalating demand for these devices in biopharma companies, as they provide access to real-time patient data for determining adherence improvement outcomes to regulators, payers, and sufferers, is expected to drive the connected drug delivery devices market in the coming years.
Who are the Key Players Operating in the Connected Drug Delivery Devices Market?
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Adherium Ltd.
- BioCorp Production
- Cohero Health Inc. (AptarGroup Inc.)
- Elcam Medical ACS. Ltd
- Findair Sp. z o. o.
- Merck KGaA
- Phillips Medisize (Molex LLC)
- Propeller Health (Resmed Inc.)
- Teva Pharmaceutical Industries Ltd.
- West Pharmaceutical Services Inc.
What is Included in Market Segmentation?
The report has categorized the market based on product, end user, technology and region.
Breakup by Product:
- Connected Sensors
- Connected Inhaler Sensors
- Connectable Injection Sensors
- Integrated Connected Devices
- Connected Inhalation Devices
- Connected Injection Devices
Based on End User:
- Hospitals and Healthcare Providers
- Homecare
Analysed by Technology:
- Bluetooth
- NFC
- Others
Regional Insights:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
